Suppr超能文献

基于支链淀粉的纳米粒作为黏膜下蛋白递药载体。

Pullulan-based nanoparticles as carriers for transmucosal protein delivery.

机构信息

CBME - Centre for Molecular and Structural Biomedicine/IBB - Institute for Biotechnology and Bioengineering, 8005-139 Faro, Portugal.

出版信息

Eur J Pharm Sci. 2013 Sep 27;50(1):102-13. doi: 10.1016/j.ejps.2013.04.018. Epub 2013 Apr 25.

Abstract

Polymeric nanoparticles have revealed very effective in transmucosal delivery of proteins. Polysaccharides are among the most used materials for the production of these carriers, owing to their structural flexibility and propensity to evidence biocompatibility and biodegradability. In parallel, there is a preference for the use of mild methods for their production, in order to prevent protein degradation, ensure lower costs and easier procedures that enable scaling up. In this work we propose the production of pullulan-based nanoparticles by a mild method of polyelectrolyte complexation. As pullulan is a neutral polysaccharide, sulfated and aminated derivatives of the polymer were synthesized to provide pullulan with a charge. These derivatives were then complexed with chitosan and carrageenan, respectively, to produce the nanocarriers. Positively charged nanoparticles of 180-270 nm were obtained, evidencing ability to associate bovine serum albumin, which was selected as model protein. In PBS pH 7.4, pullulan-based nanoparticles were found to have a burst release of 30% of the protein, which maintained up to 24h. Nanoparticle size and zeta potential were preserved upon freeze-drying in the presence of appropriate cryoprotectants. A factorial design was approached to assess the cytotoxicity of raw materials and nanoparticles by the metabolic test MTT. Nanoparticles demonstrated to not cause overt toxicity in a respiratory cell model (Calu-3). Pullulan has, thus, demonstrated to hold potential for the production of nanoparticles with an application in protein delivery.

摘要

聚合物纳米粒在蛋白质经黏膜递送上非常有效。多糖是用于生产这些载体的最常用材料之一,这是由于其结构灵活性和具有生物相容性和可生物降解性的倾向。同时,人们更倾向于使用温和的方法来生产这些载体,以防止蛋白质降解,确保更低的成本和更简单的放大程序。在这项工作中,我们提出了通过聚电解质复合的温和方法生产支链淀粉基纳米粒。由于支链淀粉是一种中性多糖,因此合成了支链淀粉的磺酸和氨基衍生物,以使支链淀粉带电。然后,将这些衍生物分别与壳聚糖和卡拉胶复合,以制备纳米载体。得到了粒径为 180-270nm 的带正电荷的纳米粒,证明能够与牛血清白蛋白结合,牛血清白蛋白被选为模型蛋白。在 PBS pH7.4 中,支链淀粉基纳米粒的蛋白释放量在 30%左右,持续 24 小时。在适当的冷冻保护剂存在下,通过冷冻干燥可以保持纳米粒的粒径和 Zeta 电位。通过 MTT 代谢试验,采用析因设计评估了原材料和纳米粒的细胞毒性。纳米粒在呼吸细胞模型(Calu-3)中未显示出明显的毒性。因此,支链淀粉具有作为蛋白质递释应用的纳米粒生产的潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验